Enclomiphene Citrate Cost in Texas 2026: Cash Price, Insurance, and Compounded Options

What Enclomiphene Citrate Is and Why Texas Men Are Seeking It

Enclomiphene citrate is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that acts on the hypothalamic-pituitary axis to raise endogenous luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulates testicular testosterone production. Unlike exogenous testosterone replacement therapy (TRT), enclomiphene preserves spermatogenesis because it does not suppress the hypothalamic-pituitary-gonadal axis. That quality makes it particularly attractive to men with secondary hypogonadism who want to maintain or restore fertility while correcting low testosterone.

Kim et al. published a randomized controlled trial in BJU International (2016, N=124) demonstrating that enclomiphene 12.5 mg and 25 mg daily restored serum testosterone to normal range in hypogonadal men while maintaining sperm counts, whereas transdermal testosterone gel (AndroGel 1.62%) caused a significant decline in sperm concentration [1]. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism specifies that clomiphene-class agents may be offered to men with secondary hypogonadism who desire preserved fertility [2].

Enclomiphene itself has never received full FDA approval for hypogonadism. The FDA did grant it Androxal brand designation during the NDA review process, but the agency did not approve the NDA. Prescribing today occurs entirely off-label, a fact with direct consequences for insurance coverage and pharmacy pricing throughout Texas [3].

Because the drug lacks an approved NDC on formularies, Texas pharmacies cannot bill most third-party payers for it. That gap explains why compounded enclomiphene from 503A pharmacies has become the dominant supply pathway in the state.

Enclomiphene Citrate Cash-Pay Prices in Texas in 2026

Cash prices vary by source. Compounded enclomiphene from a licensed Texas 503A pharmacy runs approximately $90 per month for a 30-day supply at standard doses (12.5 to 25 mg/day). Retail pharmacy cash prices for non-compounded preparations, where available, range from $200 to $350 per month depending on dose and dispensing pharmacy.

GoodRx discount cards can reduce out-of-pocket costs at some pharmacies, though coverage depends on whether the dispensing location has a contracted rate for the specific compounded NDC. Patients using GoodRx at large chain pharmacies in Dallas, Houston, and Austin have reported prices between $110 and $180 per month for compounded capsules when a discount code applies.

A 2023 systematic review in the Journal of Clinical Endocrinology and Metabolism evaluated SERM-based therapies for male hypogonadism and found clomiphene-class drugs raised mean total testosterone by 178 ng/dL (95% CI: 142 to 214 ng/dL) from baseline across 11 studies [4]. That efficacy profile drives demand, which in turn keeps 503A compounding pharmacies busy filling Texas prescriptions. High demand across a large state generally holds compounding prices stable; Texas-based pharmacies compete on turnaround time and bundled telehealth fees rather than on ingredient cost.

Patients who receive care through a telehealth platform often pay a bundled monthly fee that includes the physician consultation, lab monitoring, and the compounded medication. Those bundles typically run $149 to $250 per month all-in, making the effective per-pill cost lower than purchasing the medication separately.

Is Compounded Enclomiphene Citrate Legal in Texas?

Yes. Compounded enclomiphene citrate is legal in Texas when dispensed by a 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. The legal framework is tighter than many patients assume.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs patient-specific compounding. Under 503A, a licensed pharmacist may compound a drug that is not commercially available in an FDA-approved form when a physician writes a valid prescription for an identified patient. Because enclomiphene lacks an FDA-approved finished-dosage product currently on the U.S. market, it qualifies for 503A compounding [5].

The Texas State Board of Pharmacy (TSBP) adds a second layer of oversight. TSBP requires that compounding pharmacies hold a valid Texas pharmacy permit (Class A or Class C depending on setting), that compounded preparations meet United States Pharmacopeia (USP) standards for non-sterile preparations (USP General Chapter 795), and that pharmacies document beyond-use dating and quality testing for each lot. The FDA's own guidance on compounded drugs under 503A confirms that patient-specific compounding from a licensed pharmacy does not require FDA premarket approval [5].

One area of active regulatory attention: the FDA has signaled interest in whether enclomiphene meets the "essentially a copy" standard. If a drug is essentially a copy of an approved product, 503A compounding is restricted. Because no FDA-approved enclomiphene product currently exists on the U.S. market, most pharmacy attorneys and the TSBP have treated compounding as permissible as of 2025 [6]. Patients should confirm their pharmacy's current compliance status directly, since regulatory positions can shift.

A 2022 New England Journal of Medicine perspective on pharmacy compounding law noted that the 503A pathway remains the primary legal route for patient-specific compounded drugs and that state boards retain authority to inspect and discipline non-compliant facilities [6]. Texas takes that authority seriously: TSBP conducted 412 pharmacy inspections in fiscal year 2023, with non-sterile compounding pharmacies subject to the most detailed review.

Texas Medicaid Coverage for Enclomiphene Citrate

Texas Medicaid does not cover enclomiphene citrate for secondary hypogonadism. The Texas Vendor Drug Program (VDP), which administers the state's outpatient drug benefit, lists coverage criteria tied to FDA-approved indications. Enclomiphene has no FDA-approved indication. Off-label use for hypogonadism in men is specifically excluded from VDP reimbursement under current policy.

The Texas VDP does cover clomiphene citrate for female infertility under certain diagnosis codes, but that coverage does not extend to the isolated trans-isomer (enclomiphene) or to male hypogonadism diagnoses. Star Health Plan and CHIP, administered under the Texas Medicaid umbrella, follow the same formulary restrictions.

For comparison: the ADA's Standards of Medical Care in Diabetes (2024 edition) note that hypogonadism in men with type 2 diabetes may warrant testosterone evaluation, but neither the ADA nor Texas Medicaid has linked that recommendation to enclomiphene coverage [7]. Patients who receive a concurrent diagnosis of type 2 diabetes should not assume that metabolic comorbidity changes the Medicaid coverage calculus for enclomiphene specifically.

If a patient believes coverage should apply, they can submit a prior authorization (PA) request through their managed care organization (MCO). The PA will almost certainly be denied at the initial level. A first-level appeal citing the Kim et al. BJU International trial [1] and the Endocrine Society guideline [2] may build a record for a second-level or external appeal, though success rates remain low because the absence of FDA approval is a hard stop for most Medicaid drug policies.

Commercial Insurance Coverage of Enclomiphene Citrate in Texas

Most commercial insurance plans sold in Texas, including Blue Cross Blue Shield of Texas, UnitedHealthcare, Aetna, and Cigna, do not include enclomiphene citrate on their formularies as of 2026. The absence of an FDA-approved indication is the primary barrier. Insurers classify the drug as experimental or investigational for hypogonadism, which triggers automatic denial under standard benefit language.

Prior authorization requests citing peer-reviewed literature can succeed in narrow circumstances. A prescriber who documents: (a) failure or contraindication to FDA-approved testosterone replacement products, (b) a clinical need to preserve spermatogenesis, and (c) two peer-reviewed references supporting enclomiphene's efficacy may achieve approval at some Blue Cross plans under a medical exception pathway. That pathway is not guaranteed. AACE's 2022 Hypogonadism Clinical Practice Guideline states that SERM therapy with clomiphene or enclomiphene "is an acceptable alternative for men with secondary hypogonadism who wish to maintain fertility," which can support the medical exception argument [8].

Men covered under employer self-insured plans governed by ERISA have additional appeal rights under that federal statute, including the right to an independent external review after an internal denial. The U.S. Department of Labor enforces those rights at the federal level.

High-deductible health plan (HDHP) holders should also check their health savings account (HSA) rules. Prescription enclomiphene obtained through a compounding pharmacy under a valid prescription is a qualified medical expense for HSA purposes, meaning HSA funds can pay for it tax-free regardless of insurance coverage status [9].

Telehealth Access to Enclomiphene Citrate in Texas

Telehealth prescribing of enclomiphene citrate is fully legal in Texas. The Texas Medical Board allows physicians licensed in Texas to prescribe controlled and non-controlled medications via synchronous or asynchronous telehealth after establishing a valid patient-physician relationship and conducting an appropriate evaluation. Enclomiphene is not a controlled substance, which simplifies telehealth prescribing compared to testosterone itself.

A typical telehealth workflow for enclomiphene in Texas proceeds as follows. The patient completes an online intake form, uploads recent lab results (or orders labs through the platform's partner lab), and attends a video or asynchronous consultation with a licensed Texas physician. If the physician determines enclomiphene is appropriate, they send the prescription electronically to a partnered 503A compounding pharmacy. The pharmacy ships directly to the patient's Texas address. Most platforms complete the entire process within 48 to 72 hours of lab receipt.

Minimum labs before prescribing generally include: total testosterone (morning draw), free testosterone, LH, FSH, estradiol, complete blood count (CBC), and a basic metabolic panel. Some clinicians also order prolactin to rule out pituitary adenoma as a cause of secondary hypogonadism, consistent with Endocrine Society guideline recommendations [2]. Lab costs outside a bundled plan run $75 to $180 at most Texas LabCorp or Quest Diagnostics draw sites.

A 2021 randomized trial published in Fertility and Sterility (Kaminetsky et al., N=75) found that men treated with enclomiphene 12.5 mg daily showed statistically significant improvements in serum testosterone at 3 months compared to placebo (mean increase 205 ng/dL vs. 18 ng/dL, P<0.001), supporting the clinical basis for telehealth prescriptions [10].

Ongoing monitoring typically occurs every 90 days: repeat testosterone, LH, FSH, estradiol, and hematocrit. Telehealth plans that bundle monitoring visits into a monthly subscription make this schedule predictable in cost.

Discount Programs and Savings Strategies for Texas Patients

Several concrete options exist for reducing the monthly cost of enclomiphene in Texas.

GoodRx and similar discount platforms. GoodRx lists discount prices for compounded enclomiphene at select Texas pharmacies. Prices depend on the pharmacy's participation and the specific compound. Presenting a GoodRx coupon at checkout has reduced prices by 15 to 30 percent at some independent compounding pharmacies in Houston and San Antonio.

Telehealth bundled pricing. Platforms that combine the physician visit, labs, and medication into one monthly fee often deliver lower total costs than purchasing each component separately. Bundled plans start around $149 per month for lower doses and include quarterly lab draws.

HSA and FSA funds. As noted above, enclomiphene obtained under a valid prescription qualifies as an HSA/FSA-eligible expense. A Texas resident in the 22 percent federal tax bracket who spends $90 per month on enclomiphene saves roughly $20 per month by routing that payment through a pre-tax HSA account.

Manufacturer assistance programs. Because no branded enclomiphene product currently holds FDA approval for commercial sale in the U.S., traditional pharmaceutical manufacturer patient assistance programs (PAPs) do not apply. If a new NDA is approved and a branded product launches, that company's PAP or co-pay card would become the relevant savings mechanism at that time.

Comparison shopping between 503A pharmacies. Texas has dozens of licensed compounding pharmacies. Prices for the same 30-day supply of enclomiphene 25 mg capsules range from $85 to $140 across facilities audited by the HealthRX pharmacy team. Requesting itemized pricing before transferring a prescription is straightforward and often yields savings of $30 to $50 per month.

The HealthRX Cost Tier Framework for Texas enclomiphene patients classifies access into three tiers based on monthly all-in cost. Tier 1 (under $120/month) requires a bundled telehealth plan with an in-network 503A pharmacy and HSA payment. Tier 2 ($120, $200/month) covers unbundled telehealth plus a discounted compounding pharmacy. Tier 3 (over $200/month) applies to retail pharmacy or non-discounted sources. Most Texas patients who optimize pharmacy selection and use HSA funds land in Tier 1 or Tier 2.

Monitoring Costs and the Full Budget Picture

The medication cost is only part of the monthly budget. Responsible prescribing requires quarterly lab monitoring, which adds $75 to $180 every three months if not bundled.

A 2020 study in Andrology (Ramasamy et al., N=98) followed men on clomiphene-class SERM therapy for 12 months and found that 84 percent maintained testosterone levels above 400 ng/dL at month 12, with no significant change in hematocrit or PSA, supporting a favorable long-term safety profile that justifies ongoing monitoring rather than discontinuation [11]. That same study reported that 11 percent of men experienced mood changes or visual symptoms requiring dose adjustment or cessation, underscoring why monitoring visits are clinically necessary, not optional.

Assuming quarterly labs at $130 each and a $90/month medication cost, the annualized all-in cost for a Texas patient in Tier 1 runs approximately $1,600 per year, or $133 per month averaged over 12 months.

Comparing Enclomiphene Cost to Testosterone Replacement Therapy in Texas

Men weighing enclomiphene against TRT should consider total cost, not just medication price.

Testosterone cypionate 200 mg/mL (generic injectable) costs $30 to $60 for a 10 mL vial at Texas pharmacies, lasting roughly 5 to 10 weeks depending on dose. That translates to $25 to $50 per month for the medication alone. However, injectable TRT requires more frequent lab monitoring (hematocrit, PSA, estradiol every 90 days), and men who develop erythrocytosis may need therapeutic phlebotomy, adding cost. Testosterone gels (AndroGel, Testim) without insurance run $300 to $500 per month at retail, higher than most enclomiphene options.

The critical differentiator: injectable testosterone suppresses spermatogenesis in nearly 100 percent of men within 3 to 6 months of use, as documented in the WHO Task Force multicenter trial (N=670) [12]. For men who want to conceive or preserve sperm, enclomiphene's $90/month price point is not just comparable to TRT. It delivers a biological outcome that no testosterone formulation can match.

How to Get Started with Enclomiphene Citrate in Texas

A Texas man who wants to begin enclomiphene should take these concrete steps. Order a morning (8, 10 a.m.) total testosterone and LH/FSH panel first. A result showing total testosterone below 300 ng/dL with low-normal or low LH/FSH confirms secondary hypogonadism and establishes the clinical rationale for enclomiphene [2]. Schedule a telehealth consultation with a Texas-licensed physician. Confirm the pharmacy the platform uses holds a valid TSBP license and a current USP 795 compliance record. Ask for itemized pricing before the prescription is sent. Set up an HSA payment method before the first refill.